|
Ortega-Forte E, Hernandez-Garcia S, Vigueras G, Henarejos-Escudero P, Cutillas N, Ruiz J, Gandia-Herrero F. Potent anticancer activity of a novel iridium metallodrug via oncosis. Cell Mol Life Sci. 2022 Sep 6;79(10):510. doi: 10.1007/s00018-022-04526-5. PubMed PMID: 36066676; PubMed Central PMCID: PMC9448686.
AÑO: 2022; IF: 8.0
|
|
Bonelli, Joaquin; Ortega-Forte, Enrique; Vigueras, Gloria; Bosch, Manel; Cutillas, Natalia; Rocas, Josep; Ruiz, Jose; Marchan, Vicente. Polyurethane-polyurea hybrid nanocapsules as efficient delivery systems of anticancer Ir(III) metallodrugs. INORGANIC CHEMISTRY FRONTIERS. 2022; 9(10):2123-2138. 10.1039/d1qi01542g
AÑO: 2022; IF: 7.0
|
|
Busto N, Vigueras G, Cutillas N, Garcia B, Ruiz J. Inert cationic iridium(III) complexes with phenanthroline-based ligands: application in antimicrobial inactivation of multidrug-resistant bacterial strains. Dalton Trans. 2022 Jun 27;51(25):9653-9663. doi: 10.1039/d2dt00752e. PubMed PMID: 35713595.
AÑO: 2022; IF: 4.0
|
|
Marco A, Vigueras G, Busto N, Cutillas N, Bautista D, Ruiz J. Novel valproate half-sandwich rhodium and iridium conjugates to fight against multidrug-resistant Gram-positive bacteria. Dalton Trans. 2023 Oct 3;52(38):13482-13486. doi: 10.1039/d3dt01678a. PubMed PMID: 37358044.
AÑO: 2023; IF: 3.5
|
|
Novohradsky V, Marco A, Markova L, Cutillas N, Ruiz J, Brabec V. Ir(III) Compounds Containing a Terdentate Ligand Are Potent Inhibitors of Proliferation and Effective Antimetastatic Agents in Aggressive Triple-Negative Breast Cancer Cells. J Med Chem. 2023 Jul 27;66(14):9766-9783. doi: 10.1021/acs.jmedchem.3c00586. Epub 2023 Jul 6. PubMed PMID: 37410386; PubMed Central PMCID: PMC10388354.
AÑO: 2023; IF: 6.8
|